← SynDRA
VONOPRAZAN
SynDRA canonical compound SYN0029836 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · OTC |
|---|
| Primary target(s) | ATP4A |
|---|
| Mechanism of action | potassium-competitive acid antagonist |
|---|
| Indication | peptic ulcer disease (PUD) |
|---|
| Disease area | gastroenterology |
|---|
All known targets
Mechanisms of action (all sources)
- ATP4A INHIBITOR
- Potassium-transporting ATPase inhibitor
- ATP4B INHIBITOR
- potassium-competitive acid antagonist
- Modulator
ATC classes
- A02B · DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)
Cross-references
Synonyms
- vonoprazan fumarate
- takecab
- TAK-438
- Takecab
- Vocinti
- 1R5L3J156G
- vonoprazanum
- RefChem:56220
- A02BC08
- DTXCID00159360
- TAK-438 free base
- Vonoprazan [INN]
- Vonoprazan free base
- MFCD27987913
- Vonoprazan [USAN]
- UNII-1R5L3J156G
- Vonoprazan?
- Voquezna®
- Vonoprazan (Standard)
- VONOPRAZAN [MI]
- Vonoprazan (USAN/INN)
- Vonoprazan [USAN:INN]
- TAK-438 (free base)
- VONOPRAZAN [WHO-DD]
- SCHEMBL194487
- orb1745262
- SCHEMBL1580399
- SCHEMBL29407860
- SCHEMBL29419681
- SCHEMBL29419683
- GTPL11549
- Vonoprazan; TAK-438 free base
- CHEBI:136048
- BDBM394392
- GLXC-25655
- EX-A4002
- WHO 9535
- EBC-12130
Reported adverse events
- Abdominal pain
- Dysgeusia
- Headache
- Hypertension
- Infection
- Nasopharyngitis
- Stevens-Johnson syndrome
- Vulvovaginal candidiasis
- Abdominal distension
- Constipation
- Dyspepsia
- Enterocolitis
Look up VONOPRAZAN in the interactive SynDRA portal →